Please login to the form below

Not currently logged in

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Research

AZ secures capacity for one billion coronavirus vaccine doses

Coronavirus vaccineInitial agreement to supply 400 million doses of Oxford University’s vaccine

From: Regulatory

EMA starts review of MorphoSys’ tafasitamab for lymphoma

Drug could challenge Novartis and Gilead’s CAR-T therapies if approved

From: Regulatory

Gilead, Galapagos dip on mixed ulcerative colitis data

GileadDrug may not work well enough to displace rivals

From: Regulatory

Roche makes protein degradation play with $135m Vividion deal

Roche Basel SwitzerlandExclusive deal with Vividion includes potential for “multibillion dollar future payments”


Pharmaceutical Market Europe - May 2020

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

FDA gives Roche’s Tecentriq green light for first-line NSCLC

Company enters lucrative and competitive market dominated by Merck/MSD’s rival Keytruda

Roche Basel Switzerland

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Taking the ‘free’ out of ‘freelance’ and bringing it in-house

Let's face it, the freelance life offers numerous benefits

Stephanie Wasek

COVID-19 Updates and Daily News

Featured jobs


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...